LeMaitre Vascular Inc. (LMAT)
LeMaitre Vascular Statistics
Share Statistics
LeMaitre Vascular has 22.56M shares outstanding. The number of shares has increased by 0.66% in one year.
Shares Outstanding | 22.56M |
Shares Change (YoY) | 0.66% |
Shares Change (QoQ) | 0.07% |
Owned by Institutions (%) | 94.22% |
Shares Floating | 20.54M |
Failed to Deliver (FTD) Shares | 3.1K |
FTD / Avg. Volume | 1.48% |
Short Selling Information
The latest short interest is 1.3M, so 5.78% of the outstanding shares have been sold short.
Short Interest | 1.3M |
Short % of Shares Out | 5.78% |
Short % of Float | 6.34% |
Short Ratio (days to cover) | 5.76 |
Valuation Ratios
The PE ratio is 46.98 and the forward PE ratio is 46.44. LeMaitre Vascular's PEG ratio is 1.06.
PE Ratio | 46.98 |
Forward PE | 46.44 |
PS Ratio | 9.41 |
Forward PS | 5.9 |
PB Ratio | 6.13 |
P/FCF Ratio | 55.67 |
PEG Ratio | 1.06 |
Enterprise Valuation
LeMaitre Vascular Inc. has an Enterprise Value (EV) of 1.26B.
EV / Earnings | 28.52 |
EV / Sales | 5.71 |
EV / EBITDA | 18.81 |
EV / EBIT | 24.03 |
EV / FCF | 33.79 |
Financial Position
The company has a current ratio of 13.14, with a Debt / Equity ratio of 0.55.
Current Ratio | 13.14 |
Quick Ratio | 11.02 |
Debt / Equity | 0.55 |
Total Debt / Capitalization | 35.51 |
Cash Flow / Debt | 0.24 |
Interest Coverage | 254.91 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on capital (ROIC) is 7.74%.
Return on Equity (ROE) | 0.13% |
Return on Assets (ROA) | 0.08% |
Return on Capital (ROIC) | 7.74% |
Revenue Per Employee | $337,731.18 |
Profits Per Employee | $67,646.7 |
Employee Count | 651 |
Asset Turnover | 0.4 |
Inventory Turnover | 1.06 |
Taxes
Income Tax | 12.84M |
Effective Tax Rate | 0.23 |
Stock Price Statistics
The stock price has increased by 25.27% in the last 52 weeks. The beta is 0.88, so LeMaitre Vascular's price volatility has been higher than the market average.
Beta | 0.88 |
52-Week Price Change | 25.27% |
50-Day Moving Average | 93.06 |
200-Day Moving Average | 91.25 |
Relative Strength Index (RSI) | 39.01 |
Average Volume (20 Days) | 209.61K |
Income Statement
In the last 12 months, LeMaitre Vascular had revenue of 219.86M and earned 44.04M in profits. Earnings per share was 1.96.
Revenue | 219.86M |
Gross Profit | 150.9M |
Operating Income | 52.26M |
Net Income | 44.04M |
EBITDA | 66.75M |
EBIT | 52.26M |
Earnings Per Share (EPS) | 1.96 |
Balance Sheet
The company has 25.61M in cash and 185.69M in debt, giving a net cash position of -160.07M.
Cash & Cash Equivalents | 25.61M |
Total Debt | 185.69M |
Net Cash | -160.07M |
Retained Earnings | 145.09M |
Total Assets | 551.82M |
Working Capital | 371.58M |
Cash Flow
In the last 12 months, operating cash flow was 44.12M and capital expenditures -6.96M, giving a free cash flow of 37.16M.
Operating Cash Flow | 44.12M |
Capital Expenditures | -6.96M |
Free Cash Flow | 37.16M |
FCF Per Share | 1.66 |
Margins
Gross margin is 68.63%, with operating and profit margins of 23.77% and 20.03%.
Gross Margin | 68.63% |
Operating Margin | 23.77% |
Pretax Margin | 25.87% |
Profit Margin | 20.03% |
EBITDA Margin | 30.36% |
EBIT Margin | 23.77% |
FCF Margin | 16.9% |
Dividends & Yields
LMAT pays an annual dividend of $0.84, which amounts to a dividend yield of 0.86%.
Dividend Per Share | $0.84 |
Dividend Yield | 0.86% |
Dividend Growth (YoY) | 25% |
Payout Ratio | 43.75% |
Earnings Yield | 2.36% |
FCF Yield | 1.98% |
Analyst Forecast
The average price target for LMAT is $100, which is 20.3% higher than the current price. The consensus rating is "Buy".
Price Target | $100 |
Price Target Difference | 20.3% |
Analyst Consensus | Buy |
Analyst Count | 9 |
Scores
Altman Z-Score | 7.21 |
Piotroski F-Score | 6 |